Index NDX, S&P 500
P/E 40.20
EPS (ttm) 14.34
Insider Own 0.37%
Shs Outstand 107.30M
Perf Week 0.18%
Market Cap 61.92B
Forward P/E 26.72
EPS next Y 21.58
Insider Trans -9.59%
Shs Float 106.99M
Perf Month 0.45%
Income 1.55B
PEG 4.02
EPS next Q 4.75
Inst Own 93.81%
Short Float 1.30%
Perf Quarter 9.48%
Sales 7.04B
P/S 8.80
EPS this Y 9.06%
Inst Trans 0.20%
Short Ratio 2.23
Perf Half Y 2.82%
Book/sh 175.84
P/B 3.28
EPS next Y 8.10%
ROA 5.21%
Short Interest 1.39M
Perf Year 4.08%
Cash/sh 1.75
P/C 329.03
EPS next 5Y 9.99%
ROE 8.53%
52W Range 499.47 - 595.17
Perf YTD 10.93%
Dividend Est. 2.99 (0.52%)
P/FCF 26.61
EPS past 5Y -3.13%
ROI 6.05%
52W High -3.11%
Beta 1.07
Dividend TTM 3.08 (0.53%)
Quick Ratio 0.36
Sales past 5Y 6.02%
Gross Margin 69.30%
52W Low 15.45%
ATR (14) 9.82
Dividend Ex-Date Apr 04, 2025
Current Ratio 0.39
EPS Y/Y TTM 13.02%
Oper. Margin 28.37%
RSI (14) 52.72
Volatility 1.28% 1.71%
Employees 18200
Debt/Eq 0.41
Sales Y/Y TTM 13.94%
Profit Margin 22.01%
Recom 2.16
Target Price 639.67
Option/Short Yes / Yes
LT Debt/Eq 0.36
EPS Q/Q 22.01%
Payout 21.44%
Rel Volume 0.92
Prev Close 572.18
Sales Surprise 2.18%
EPS Surprise 1.72%
Sales Q/Q 16.34%
Earnings Jan 30 BMO
Avg Volume 623.00K
Price 576.65
SMA20 -0.20%
SMA50 2.28%
SMA200 4.35%
Trades
Volume 568,913
Change 0.78%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-28-25 Upgrade
TD Cowen
Hold → Buy
$535 → $615
Dec-23-24 Resumed
Oppenheimer
Outperform
$630
Dec-05-24 Downgrade
Barclays
Overweight → Underweight
$625 → $569
Jul-25-24 Upgrade
Robert W. Baird
Neutral → Outperform
$617 → $635
Jun-13-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Mar-22-24 Reiterated
Oppenheimer
Outperform
$580 → $650
Jan-04-24 Downgrade
TD Cowen
Outperform → Market Perform
$535
Jul-24-23 Resumed
Wolfe Research
Outperform
$558
Jun-27-23 Initiated
Jefferies
Buy
$530
May-02-23 Upgrade
Bernstein
Underperform → Mkt Perform
$490 → $525
Mar-23-23 Initiated
Mizuho
Neutral
$475
Mar-22-23 Upgrade
JP Morgan
Underweight → Neutral
$385 → $420
Mar-20-23 Initiated
Truist
Buy
$510
Feb-23-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$480
Aug-17-22 Initiated
Bernstein
Mkt Perform
$505 → $490
Jan-11-22 Initiated
Bernstein
Mkt Perform
$505
Dec-17-21 Initiated
Mizuho
Buy
$550
Dec-15-21 Initiated
Wolfe Research
Peer Perform
$487
Oct-04-21 Upgrade
Raymond James
Outperform → Strong Buy
$550
Jun-30-21 Reiterated
Oppenheimer
Outperform
$505 → $560
Show Previous Ratings
Today 06:02AM
Mar-24-25 10:46PM
02:30PM
09:00AM
08:38AM
08:30AM
Loading…
08:30AM
Mar-20-25 06:20AM
Mar-19-25 06:20AM
Mar-18-25 10:45AM
Mar-13-25 09:15AM
Mar-11-25 04:34AM
Mar-09-25 06:00AM
Mar-07-25 02:45PM
02:00PM
Mar-05-25 01:00PM
11:40AM
Loading…
11:40AM
Mar-04-25 12:36PM
Mar-03-25 10:00AM
Feb-25-25 08:30AM
Feb-24-25 11:00AM
11:00AM
09:51AM
Feb-17-25 07:39AM
Feb-15-25 09:45AM
Feb-13-25 09:00AM
Feb-10-25 11:00AM
Jan-31-25 02:31AM
Jan-30-25 09:57PM
(Morningstar Research) +5.08%
02:09PM
10:03AM
09:30AM
Loading…
09:30AM
08:25AM
08:05AM
07:17AM
(Associated Press Finance)
06:55AM
Jan-29-25 10:30AM
Jan-24-25 12:27PM
Jan-23-25 03:20PM
Jan-22-25 11:00AM
Jan-21-25 01:00PM
Jan-06-25 08:30AM
Jan-02-25 12:10PM
10:03AM
Dec-30-24 04:25AM
Dec-25-24 09:45AM
Dec-23-24 09:32AM
Dec-20-24 12:46PM
Dec-19-24 07:49PM
Dec-17-24 12:00PM
12:00PM
Dec-16-24 01:30AM
Dec-12-24 09:05AM
Nov-28-24 11:32AM
Nov-26-24 08:30AM
Nov-19-24 10:03AM
09:00AM
Nov-06-24 01:00PM
Nov-02-24 01:04AM
Oct-30-24 10:03AM
Oct-29-24 10:18AM
10:00AM
Oct-28-24 11:00AM
Oct-25-24 09:20AM
Oct-24-24 03:04AM
02:00AM
(Thomson Reuters StreetEvents)
Oct-23-24 03:43PM
09:30AM
09:00AM
09:00AM
08:06AM
08:05AM
07:03AM
(Associated Press Finance)
06:55AM
Oct-18-24 09:15AM
Oct-16-24 09:04AM
Oct-15-24 11:26AM
Oct-09-24 04:36PM
Oct-04-24 09:00AM
07:00AM
(Investor's Business Daily)
Oct-02-24 05:00AM
Sep-18-24 01:58PM
12:00PM
Sep-16-24 10:03AM
Sep-04-24 09:00AM
Sep-03-24 08:50AM
Aug-27-24 10:29AM
09:00AM
Aug-23-24 11:31AM
09:00AM
Aug-22-24 12:00PM
10:01AM
Aug-21-24 10:12AM
Aug-19-24 07:00PM
07:54AM
Aug-16-24 02:09PM
Aug-15-24 08:37AM
08:30AM
08:30AM
Jul-30-24 09:00AM
Jul-26-24 05:44PM
Roper Technologies, Inc. is a diversified technology company, which engages in the provision of engineered products and solutions for global niche markets. It operates through the following segments: Application Software, Network Software, and Technology Enabled Products. The Application Software segment includes Aderant, CBORD/Horizon, CliniSys, Data Innovations, Deltek, Frontline Education, IntelliTrans, PowerPlan, Strata, and Vertafore. The Network Software segment is composed of ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment refers to CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. The company was founded by George D. Roper in 1890 and is headquartered in Sarasota, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Conley Jason EVP, Chief Financial Officer Feb 25 '25 Option Exercise 165.97 3,000 497,910 34,522 Feb 26 04:30 PM Conley Jason EVP, Chief Financial Officer Feb 25 '25 Sale 588.19 3,000 1,764,570 31,522 Feb 26 04:30 PM Conley Jason Officer Feb 25 '25 Proposed Sale 588.19 3,000 1,764,567 Feb 25 01:01 PM Cross Brandon L VP and Corporate Controller Feb 04 '25 Option Exercise 235.25 750 176,438 2,079 Feb 05 04:30 PM Cross Brandon L VP and Corporate Controller Feb 04 '25 Sale 577.83 750 433,373 1,329 Feb 05 04:30 PM Cross Brandon L Officer Feb 04 '25 Proposed Sale 577.83 750 433,374 Feb 04 03:37 PM Conley Jason EVP, Chief Financial Officer Jan 31 '25 Option Exercise 165.97 3,000 497,910 34,522 Feb 03 04:00 PM Conley Jason EVP, Chief Financial Officer Jan 31 '25 Sale 578.05 3,000 1,734,150 31,522 Feb 03 04:00 PM Stipancich John K Executive VP, GC & Secretary Jan 31 '25 Option Exercise 228.84 1,000 228,840 39,932 Feb 03 04:00 PM Stipancich John K Executive VP, GC & Secretary Jan 31 '25 Sale 578.04 1,000 578,040 38,932 Feb 03 04:00 PM WALLMAN RICHARD F Director Jan 31 '25 Sale 575.25 351 201,913 20,187 Feb 03 04:00 PM WALLMAN RICHARD F Director Jan 31 '25 Proposed Sale 575.25 351 201,913 Jan 31 04:09 PM Stipancich John K Officer Jan 31 '25 Proposed Sale 578.04 1,000 578,042 Jan 31 01:01 PM Conley Jason Officer Jan 31 '25 Proposed Sale 578.05 3,000 1,734,143 Jan 31 12:27 PM JOHNSON ROBERT D Director Dec 03 '24 Sale 561.80 940 528,092 4,219 Dec 04 04:30 PM SABRINA & ROBERT TRUST Director Dec 03 '24 Proposed Sale 561.80 940 528,089 Dec 03 04:23 PM HUNN LAURENCE NEIL President and CEO Nov 08 '24 Option Exercise 156.40 30,000 4,692,000 117,311 Nov 12 04:12 PM HUNN LAURENCE NEIL President and CEO Nov 08 '24 Sale 572.47 30,000 17,174,101 87,311 Nov 12 04:12 PM WRIGHT CHRISTOPHER Director Nov 08 '24 Sale 568.82 681 387,366 34,869 Nov 12 04:12 PM WRIGHT CHRISTOPHER Director Nov 08 '24 Proposed Sale 568.82 681 387,366 Nov 12 12:42 PM HUNN LAURENCE NEIL Officer Nov 08 '24 Proposed Sale 572.47 30,000 17,174,091 Nov 08 01:52 PM WALLMAN RICHARD F Director Oct 24 '24 Sale 550.00 1,000 550,000 0 Oct 28 04:06 PM WALLMAN RICHARD F Director Oct 24 '24 Sale 550.00 1,000 550,000 32,955 Oct 28 04:06 PM WALLMAN RICHARD F Director Oct 25 '24 Sale 547.00 417 228,099 32,538 Oct 28 04:06 PM WALLMAN RICHARD F Director Oct 28 '24 Proposed Sale 544.00 2,000 1,088,000 Oct 28 04:04 PM WALLMAN RICHARD F Director Oct 25 '24 Proposed Sale 547.00 417 228,099 Oct 25 04:25 PM WALLMAN RICHARD F Director Oct 24 '24 Proposed Sale 550.00 2,000 1,100,000 Oct 24 04:25 PM JOHNSON ROBERT D Director Sep 13 '24 Sale 553.78 750 415,335 5,159 Sep 17 04:09 PM SABRINA & ROBERT TRUST Officer Sep 13 '24 Proposed Sale 553.78 750 415,338 Sep 13 05:25 PM JOHNSON ROBERT D Director Jul 26 '24 Sale 550.34 140 77,048 5,909 Jul 29 04:05 PM SABRINA & ROBERT TRUST U/T/A D Officer Jul 26 '24 Proposed Sale 550.34 140 77,047 Jul 26 04:37 PM Conley Jason EVP, Chief Financial Officer Jun 20 '24 Sale 563.02 3,500 1,970,555 33,685 Jun 21 04:30 PM WRIGHT CHRISTOPHER Director Jun 18 '24 Sale 551.74 400 220,696 35,550 Jun 20 04:15 PM WRIGHT CHRISTOPHER Director Jun 07 '24 Sale 554.67 300 166,401 35,247 Jun 10 04:50 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite